Emerging evidence indicates that ingestion of specific probiotics, known as "psychobiotics", confer beneficial effects on mental health. This study investigated antidepressant-like effects and possible underlying mechanisms of Lactobacillus paracasei PS23 (PS23), live or heat-killed, in a mouse model of corticosterone-induced depression using fluoxetine as standard drug. PS23 were orally gavaged to mice from day 1 to 41 or fluoxetine from day 17 to 41 and injected with corticosterone from day 17 to 37. After the last corticosterone treatment, anxiety-and depression-like behaviors were tested within 4 days. On day 42, serum and brain tissue were collected 24 minutes after forced swim stress. Furthermore, both live and heat-killed PS23 and fluoxetine reversed corticosterone-reduced protein levels of brain-derived neurotropic factor, mineralocorticoid, and glucocorticoid receptors in the hippocampus. In addition, live PS23 also reverses corticosterone-reduced serotonin levels in hippocampus, prefrontal cortex and striatum; whereas heat-killed PS23 reverses corticosterone-reduced dopamine levels in hippocampus and prefrontal cortex. And fluoxetine normalized reduced corticosterone level in serum. These studies showed that both live and heat-killed PS23 can reverse chronic corticosterone-induced anxiety-and depression-like behaviors and that may provide insights into the mechanism and a potential psychobiotic for depression management.
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Introduction
Major depressive disorder (MDD), also referred as depression, is a mental disorder with a high prevalence rate. The symptoms of MDD should include at least one of the two main symptoms such as depressed mood and anhedonia and accompanied by at least four of additional symptoms like weight changes, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness or excessive guilt, inability to concentrate, and recurrent thoughts of death or suicide and the symptoms should last more than 2-weeks (Association, 2013) . MDD often presents with recurrent episodes and is comorbid with other chronic diseases, such as angina, arthritis, asthma, and diabetes (Moussavi et al., 2007) . According to the Global Burden of Disease studies, MDD is a leading cause of burden (Ferrari et al., 2013) . Although the etiology of the disease is still not fully understood, previous studies have shown that the dysregulation of hypothalamic-pituitary-adrenal (HPA) axis is causal for stress-related illnesses, including depression (Juruena et al., 2004; Swaab et al., 2005) . The HPA axis is activated in response to stress, which results in increased concentration of glucocorticoids in the circulating blood (Herman and Cullinan, 1997) .
However, excessive glucocorticoids induced by repeated stress can impair the hippocampal feedback function on glucocorticoids (Sapolsky et al., 1984) , leading to hyperactivity of the HPA axis. Such HPA axis dysfunction has been associated with the development of MDD (Checkley, 1996) .
Monoamine neurotransmitters, especially serotonin (5-hydroxytryptamine, 5-HT) and dopamine, are also affected by stress (Castro and Zigmond, 2001; Chaouloff et al., 1999) . In particular, serotonin is a key regulator of glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs) expression and has been shown to increase their expression in hippocampal neurons (Lai et al., 2003; Meltzer, 1989) . Furthermore, serotonergic pathways, such as those innervating the hippocampus, amygdala, frontal cortex and hypothalamus, are also activated by anxiogenic stimuli (Millan, 2003) . However, both an increase and a decrease of 5-HT activity has been associated with negative emotions (Tõnissaar et al., 2004) . In contrast, dopamine is present mainly in the frontal cortex and striatum (Miyazaki and Asanuma, 2008) . The release of dopamine may prevent excessive activation of the HPA axis via the negative feedback loop, which is important for stress adaption (Sullivan and Dufresne, 2006) . Moreover, brain-derived neurotropic factor (BDNF), a predominant neuronal growth factor in the brain, regulates neuronal survival, differentiation, and synaptic plasticity (Thoenen, 1995) . Numerous studies have demonstrated that stress decreases the expression of BDNF in the limbic structure, whereas antidepressant treatment increases the BDNF concentration (Duman and Monteggia, 2006) .
The currently used antidepressants mainly block the reuptake or degradation of monoamines (Berton and Nestler, 2006) . Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac), are often used as the first-line drug for depression treatment (Coplan et al., 2014) . Although these monoamine-related antidepressants offer better therapeutic responses and fewer side effects, they have therapeutic delays and require long-term medication to maintain remission; and about 30% of MDD patients are unresponsive to treatment (Krishnan and Nestler, 2008; Trivedi et al., 2006) . Therefore, the search for new and more effective treatment agents continues.
Recently, there has been an increasing interest in the relationship between dysfunction of the gut-brain axis, a complex communication between gut microbiota and the brain, and MDD (Borre et al., 2014; Dinan et al., 2013; Farzi et al., 2018) . In three randomized double-blind or triple-blind placebo-control clinical trials, elderly volunteers, healthy young students, or healthy adults were receiving Lactobacillus casei (Benton et al., 2007) , multi-species probiotics (Steenbergen et al., 2015) , or a combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 (Messaoudi et al., 2011) , respectively. Subjects in the first and second trials exhibited improved mood and those in the third experienced alleviated psychological distress and a decrease in urinary free cortisol output.
Furthermore, in two placebo-control clinical trials, administrations of Lactobacillus plantarum 299v or B. longum 1714 reversed the increased cortisol levels in students with an upcoming exam (Andersson et al., 2016) or in healthy volunteers exposed to an acute stressor (Allen et al., 2016) , respectively. An animal study showed that, compared to specific pathogen free mice, germ-free (GF) mice lacking gut microbiota displayed higher adrenocorticotropic hormone and corticosterone levels in plasma and lower BDNF expression in the cortex and hippocampus when exposed to restraint stress, and hyperactivity of the HPA axis in GF mice could be reversed by reconstitution with Bifidobacterium infantis (Sudo et al., 2004) . Furthermore, administrations of Bifidobacterium pseudocatenulatum CECT 7765 (Moya-Pérez et al., 2017) , L. plantarum PS128 (Liu et al., 2016b) or Lactobacillus rhamnosus (Bravo et al., 2011) have shown beneficial effects on depression-and anxiety-related behaviors, stress-induced increases of corticosterone in a rodent maternal separation model of early life-stress (ELS), or acute stress in mice, respectively. L. plantarum PS128 also increased the dopamine level in the prefrontal cortex in ELS mice (Liu et al., 2016b) . Recently, B. pseudocatenulatum CECT 7765 was further found to have reversed the depressive-and anxiety-like behaviors and the altered fecal corticosterone and hippocampal 5-HT levels in obese mice after acute stress (Agusti et al., 2018) . Therefore, targeting microbiota, that is, utilizing "psychobiotics" for its beneficial impact on brain and behaviors, is a promising strategy (Dinan et al., 2015) . Nevertheless, most of the abovementioned studies mainly focused on live probiotics, whereas the use of dead probiotics has several attractive advantages; including safety and long shelf-life for commercial products. In a recent study, repeated subcutaneous immunization with a heat-killed preparation of Mycobacterium vaccae, an immunoregulatory environmental microorganism, induced anxiolytic effects in a murine model of chronic psychosocial stress (Reber et al., 2016) . On the other hand, only live but not heat-killed L. plantarum PS128 showed improve anxiety-like behaviors and increased serotonin and dopamine levels in GF mice (Liu et al., 2016a ). These results illustrated that different probiotics under different preparations might have different anxiolytic effects.
Live preparation of Lactobacillus paracasei PS23 (PS23) were previously investigated and shown to have the capacity to delay age-related cognitive decline, improve anxiety-like behaviors, and increase serotonin and dopamine levels in both the hippocampus and striatum in senescence-accelerated mouse prone 8 (SAMP8) mice (Huang et al., 2018) . Recently, the administration of live and heat-killed PS23 further shown to improve anxiety-and depression-like behaviors, lower serum corticosterone levels, which is accompanied by higher serum anti-inflammatory interleukin (IL)-10 levels, in maternal separation mice (Liao et al., In Press) . The aim of this study is to explore the potential antidepressant properties of live and heat-killed PS23 by using a mice depression model of repeated corticosterone injection and compare the effects to that of fluoxetine treatment. We evaluated the effects of chronic administration of live or heat-killed PS23 (L-PS23 or H-PS23, respectively) on anxiety-like behaviors in open field test (OFT) and depression-like behaviors in the forced swim test (FST) and sucrose preference test (SPT). To explore possible underlying mechanisms of the behavioral effects of PS23, we measured the plasma corticosterone concentration and expression of MR, GR, and BDNF in the hippocampus following FST.
Finally, we measured the 5-HT and dopamine concentrations in the hippocampus, prefrontal cortex, and striatum.
Results

Chronic administration of PS23 and corticosterone do not affect body weight
Mice in all groups (Fig 1) showed slight weight gain weekly, and during the 6-week experimental period the body weight increased 11-19%. The relative body weights measured weekly were not significantly different among groups (data not shown).
PS23 reverses corticosterone treatment-induced anxiety-like behaviors in the OFT
Mice treated with corticosterone for 21 days (corticosterone control group) exhibited significant anxiety-like behaviors in the OFT as compared to the vehicle group (Fig. 2) .
Twenty-five days of fluoxetine treatment (positive drug) and 41 days of treatment with L-PS23 or H-PS23 completely reverted the reduction in total distance traveled caused by chronic corticosterone administration ( Fig. 2A) . L-PS23 also reversed the reduction in central/total distance ratio (Fig. 2B) . The reduction in time spent in the center area and the number of entries into the center area was also reversed by chronic fluoxetine, L-PS23, or H-PS23 treatments (Fig. 2C-D) .
PS23 reverses corticosterone treatment-induced depression-like behaviors in the FST
In the FST, chronic corticosterone treatment significantly increased the immobile period in the corticosterone group as compared to the vehicle group. Treatments with H-PS23 or fluoxetine significantly reduced the immobile time induced by chronic corticosterone exposure, whereas L-PS23 treatment was ineffective.
PS23 improves corticosterone treatment-induced depression-like behaviors in the SPT
The results of SPT showed the corticosterone group had significantly reduced sucrose preference as compared to that of the vehicle group. However, post hoc analysis did not show significant differences in between different treatment groups and the corticosterone group.
Nevertheless, both L-PS23-and H-PS23-treated mice showed slight improved sucrose preference as well as that of the vehicle group (P > 0.05).
PS23 does not affect corticosterone-suppressed serum corticosterone elevation under stress condition
The basal serum corticosterone level was similar among treatment groups (Fig. 4) . Under the stress condition (24 min after a 6-min FST), the vehicle group showed a significant elevation of serum corticosterone level (basal: interquartile range 46.2-92.6 ng/ml; stress: interquartile range 292.5-429.6 ng/ml). Chronic corticosterone treatment significantly reduced the stress-induced corticosterone elevation in the corticosterone group (interquartile range 145.4-214.0 ng/ml) as compared to that of the vehicle group. Fluoxetine treatment reversed this chronic corticosterone treatment-induced reduction of corticosterone elevation under stress, whereas L-PS23 and H-PS23 treatment had no effects (fluoxetine: interquartile range 315.2-426.1 ng/ml; L-PS23: interquartile range 158.1-217.1 ng/ml; H-PS23: interquartile range 142.1-170.1 ng/ml).
PS23 attenuates corticosterone-induced reduction in hippocampal MR, GR, and BDNF protein levels
We quantified the protein levels of MR, GR, and BDNF in the hippocampus collected 24 min after the FST by Western blot (Fig. 5) . All the proteins in the chronic corticosterone-treated control mice showed significant reductions as compared to the vehicle group. These reductions were reversed by L-PS23, H-PS23, or fluoxetine treatment. The effect of H-PS23 treatment on MR protein level was superior to that of fluoxetine and L-PS23 treatments (Fig.   5A ).
PS23 reverses corticosterone-induced reduction in dopamine and 5-HT levels and changes in their turnover rates
The concentrations of dopamine, 5-HT, and their metabolites in the hippocampus, prefrontal cortex, and striatum were quantified using HPLC-ECD. When compared to the vehicle group, the concentrations of dopamine and 5-HT in the hippocampus, prefrontal cortex, and striatum were all significantly reduced in the corticosterone group (Table 1) . Chronic fluoxetine treatment did not reverse the reduction in dopamine, 5-HT, and changes in dopamine turnover rate, whereas H-PS23 treatment group significantly reversed the reduced dopamine levels in hippocampus and prefrontal cortex compared to that of the corticosterone group (Table 1 ). In addition, the H-PS23 and L-PS23 treatment groups both showed significantly decreased ratios of DOPAC/dopamine in the hippocampus (Table 1) . On the other hand, only L-PS23 treatment significantly reversed the corticosterone-induced reduction in 5-HT levels in the hippocampus, prefrontal cortex, and striatum (Table 1) . Interestingly, such effects were not found in the fluoxetine or H-PS23 treatment groups (Table 1) .
Discussion
It is well established that depression is associated with dysfunction of the HPA axis (Juruena et al., 2004; Swaab et al., 2005) . Past studies have also demonstrated that the gut microbiome plays an important role in the development and regulation of the HPA axis (Farzi et al., 2018) .
Experiments using GF mice (Sudo et al., 2004 ) and animal models of maternal separation (Liu et al., 2016b; Moya-Pérez et al., 2017) , acute stress (Bravo et al., 2011) , and diet-induced obesity (Agusti et al., 2018) showed that there were beneficial effects of lactic acid bacteria on HPA axis activity and its related behaviors. Here, we used chronic administration of exogenous corticosterone in mice to mimic dysfunction of the HPA axis and produced anxiety-and depression-like behaviors. This animal model of depression exhibits many of the core symptoms of human depression and has been reported to be effective and reliable for screening antidepressants and for exploring the pharmacological mechanisms (Johnson et al., 2006; Sterner and Kalynchuk, 2010; Zhao et al., 2008) . We believe this is the first study to examine the effects of chronic administration of live or heat-killed lactic acid bacteria on chronic corticosterone-induced physiological and behavioral changes and compared to the effects of fluoxetine treatment.
We used FST to examine depressive-like behaviors, SPT for testing anhedonic behaviors, and OFT for anxiety-like behaviors. Consistent with previous studies (Ding et al., 2018; Lee et al., 2015) , a 21-day regimen of daily corticosterone administration significantly increased the depression-and anxiety-like behaviors (Figs. 2 and 3). In the OFT we observed a clear reduction in the total distance traveled in the corticosterone group ( Fig. 2A) . The reduced total locomotor activity in OFT were also reported in a study using C57BL/6J mice implanted with corticosterone pellets for 21 days (Sturm et al., 2015) . To adjust for the reduced activity, the ratio central/total locomotor activity ( Fig. 2B ) was therefore used for indication of the anxiogenic effect and for easy comparison with other studies (David et al., 2009; Kutiyanawalla et al., 2011) . Consistent with previous studies, chronic fluoxetine treatment was able to reverse the behavioral effects caused by chronic corticosterone administration in the FST and OFT, but not in the SPT (Lee et al., 2015) . However, the reversed effects of fluoxetine treatment on both FST and SPT (Yan et al., 2016; Yi et al., 2012) or only on OFT but not FST (David et al., 2009) were also observed. Chronically administrated L-PS23 or H-PS23 resulted in similar anxiolytic effects in the OFT, however only H-PS23 had antidepressant-like effects, as shown by the FST (Figs. 2 and 3A ). For anhedonic behaviors, both L-PS23-and H-PS23 showed slight improvement in the SPT with no significant difference as compared to the vehicle group (Fig. 3B ). To sum up the abovementioned studies, the H-PS23 treatment effect is better than that of fluoxetine or L-PS23.
The response of the HPA axis to stress is an important behavioral adaptation. It is tightly regulated through a negative feedback mechanism involving the hippocampus, hypothalamus, and pituitary to control glucocorticoid secretion (Mora et al., 2012) . In our chronic corticosterone-induced depression mice model, the basal serum corticosterone level showed no significant change and their corticosterone level only showed minor elevation in response to acute swim stress (Fig. 4) . We believe it is likely due to adaptation to chronic corticosterone administration. These observations are consistent with previous reports in mice (Kinlein et al., 2015; Kott et al., 2016; Mishima et al., 2015; Xu et al., 2011) . Interestingly, the blunted cortisol response following stress is also observed in MDD patients (Burke et al., 2005) . Unlike fluoxetine treatment, which normalized the serum corticosterone response after stress, L-PS23 and H-PS23 treatments showed no recovery in this regard (Fig. 4) . However, there was significant recovery of hippocampal MR and GR protein levels, similar to that of fluoxetine treatment ( Fig. 5A and B).
The hippocampal protein levels of MR and GR were both reduced in chronic corticosterone-administrated mice ( Fig. 5A and B) . Similar results were also found in mice implanted with corticosterone-releasing pellets for 1 week (Hodes et al., 2012) . However, other studies reported that mice chronically exposed to corticosterone showed a reduction only in the hippocampal MR (Wu et al., 2013; Xu et al., 2011) . This discrepancy might be due to the corticosterone administration method, dosage, and the brain sample collection time after the behavioral test (Wu et al., 2013) . It is reported that in adrenalectomized rat, nuclear translocation of GRs rapidly peaked at 15 min after a corticosterone injection, and by 30 min the GR level already showed significant reduction from the peak value, and there was no significant change in cytoplasmic receptors during this period (Conway-Campbell et al., 2007) . In another study, acute elevated-platform stress also rapidly increased nuclear GR protein in the dorsal hippocampus within 10 min and then showed a significant decline by 60 min; whereas nuclear MR proteins in the dorsal and ventral hippocampus were both increased at 60 min (Caudal et al., 2014 ). In the current study, we used whole cell extract to quantify hippocampal GR and MR concentrations. This method cannot distinguish among the nuclear, cytoplasmic, and membrane-bound receptors. The decreased GRs and MRs we saw may be the nuclear, cytoplasmic, or the membrane-bound receptors which were thought to mediate non-genomic signaling accounted for rapid negative feedback inhibition of the HPA axis (Joëls et al., 2012) . However, since we had collected our hippocampal samples at 24 min after the FST, the nuclear GR might have already been in its decline phase. It is also possible that this dynamic change in nuclear GR is altered in chronic corticosterone-treated mice, so what we saw might be an enhanced rapid degradation of nuclear GR. Alternatively, it could be a general reduction in GR and MR production. Clinically, a reduction in the mRNA levels of hippocampal MRs and GRs was observed in human postmortem studies of MDD patients (López et al., 1998; Webster et al., 2002) . Dopamine is reduced after sustained exposure to stress or corticosterone, and long-term exposure to high corticosterone levels also attenuates 5-HT responses in the hippocampus (de Kloet et al., 2005; Karten et al., 1999) . Stress also reduces the BDNF concentration in the hippocampus, which is mediated both by glucocorticoid and by increasing serotonergic transmission (Hecimovic, 2012) . Reduction of BDNF and 5-HT was also reported in a previous study of chronic corticosterone-treated mice, in which the hippocampal sample was collected immediately after behavioral tests (Freitas et al., 2016) . Consistent with previous findings, we found that chronic corticosterone administration reduced levels of dopamine and 5-HT in the hippocampus, prefrontal cortex, and striatum (Table 1) and BDNF proteins in the hippocampus (Fig. 5C ). On the other hands, no significant differences in dopamine, 5-HT levels and GR expression but reduced BDNF expression were found in the hippocampus collected from the chronic corticosterone-treated mice one day after the last behavioral test (Demuyser et al., 2016) . Taken together, our results and abovementioned studies suggest that dopamine and 5-HT might have a role in regulating rapid negative feedback inhibition of the HPA axis as GR. More importantly, our results indicated that these reductions can be reversed by chronic L-PS23 or/and H-PS23 treatments, whereas chronic fluoxetine treatment only reversed MR, GR, and BDNF levels in the hippocampus and had no effect on the reduced brain monoamines (Fig. 5, Table 1 ).
SSRIs increase synaptic 5-HT by blocking 5-HT reuptake. Long-term treatment with SSRIs also desensitizes the presynaptic autoreceptors and enhances 5-HT neurotransmission (Blier, 2001; Quesseveur et al., 2013) . In our chronic corticosterone-administrated mice, long-term treatment with fluoxetine had no clear effects on 5-HT and dopamine levels in the hippocampus, prefrontal cortex, or striatum (Table 1) . However, chronic fluoxetine treatment normalized the serum corticosterone response after stress and reversed the reductions in the hippocampal MR, GR and BDNF proteins, suggesting an effect on the HPA axis regulation (Figs. 4 and 5). We also noted anxiolytic and antidepressant-like effects of long-term fluoxetine treatment, as shown by the OFT and FST (Figs. 2 and 3A) . These beneficial effects of chronic fluoxetine treatment have been observed previously (Lee et al., 2015; Sawamoto et al., 2016; Yi et al., 2012) . Also, in clinical settings, chronic fluoxetine treatment led to a decrease in serum cortisol in MDD patients (Piwowarska et al., 2012) . Despite SSRIs having better overall safety and tolerability than older antidepressants, troublesome adverse effects such as sexual dysfunction, weight gain, and sleep disturbance might arise in long-term SSRI therapy (Ferguson, 2001) . Particularly, in fluoxetine-treated patients, insomnia, agitation, tremor, anxiety, and gastrointestinal adverse effects were significantly more frequent (Brambilla et al., 2005) . In addition, symptoms including dizziness, nausea, lethargy, headache, anxiety, and agitation have been reported after withdrawal from the drug (Ferguson, 2001 ). Therefore, alternative therapeutic strategy is much needed in MDD treatment.
Accumulating preclinical studies have revealed that chronic stress results in an altered gut microbial composition (Bailey et al., 2011; Bharwani et al., 2017; Burokas et al., 2017; de Wouw et al., 2018; Dunphy-Doherty et al., 2018; Galley et al., 2017; Marin et al., 2017; Szyszkowicz et al., 2017) . Regarding the communication between the gut microbiota and the HPA axis, it has been reported that rats exposed to maternal separation during pre-weaning period or restraint stress during adulthood significantly increased plasma adrenocorticotropic hormone levels and fecal counts of clostridia, Escherichia coli, or enterococci; with reduced bifidobacteria and no effect on lactobacilli by using qPCR quantification of the fecal microflora (Barouei et al., 2012) . In another study, qPCR results corroborate the lower concentration of Bifidobacterium but also found a reduction in Lactobacillus in the cecum of acute FST-stressed mice that also showed increased plasma corticosterone levels (Burokas et al., 2017) . Therefore, we used qPCR to target specific rRNA genes of the taxa Bifidobacterium, the Clostridium coccoides group, Enterobacteriaceae, and Enterococcus, as well as Lactobacillus, the taxon of PS23, to verify the abundance of these bacteria in mice feces from different treatment groups (Supplemental Fig. 1 ). Chronic corticosterone treatments caused significant decreases in both Bifidobacterium and the C. coccoides groups compared to that of the vehicle group (Bifidobacterium, vehicle: interquartile range 9.50-10.68 Log CFU/g, corticosterone control: interquartile range 7.95-8.77 Log CFU/g; C.
coccoides group, vehicle: 10.35 ± 0.17 Log CFU/g, corticosterone control: 9.93 ± 0.07 Log CFU/g). Long-term fluoxetine treatment not only significantly reduced Bifidobacterium (interquartile range 5.52-5.81 Log CFU/g) but also increased the C. coccoides group (10.46 ± 0.07 Log CFU/g) compared to the corticosterone group. In contrast, both L-PS23 and H-PS23 showed normalization of resident Bifidobacterium with no significant change in the C. coccoides group; although changes in Bifidobacterium in H-PS23 group did not reach statistical significance compared with either the vehicle or corticosterone groups. Recently, atypical antipsychotic treatment in bipolar disorder patients is reported to associate with changes in the gut microbiota communities (Flowers et al., 2017) . After screening more than 1,000 marketed drugs against 40 human gut bacterial isolates, nearly all subclasses of the chemically diverse antipsychotics exhibited anticommensal activity (Maier et al., 2018) . In addition, fluoxetine-treated rats have been reported to induce minor but significant changes in gut microbiota composition including Deferribactere and the genera Prevotella 7, Prevotella 9 and Succinivibrio. However, such changes do not parallel with its antimicrobial effects on isolated bacterial strains of L. rhamnosus and E. coli in vitro (Cussotto et al., 2018) .
Psychological stress, including acute and chronic stress, has marked impacts on gastrointestinal sensitivity, motility, secretion, and permeability (Qin et al., 2014) . The potential mechanism is correlated with mucosal immune activation and alterations in the central nervous system, probably via a link between peripheral neurons and gastrointestinal microbiota (Qin et al., 2014) . In GF mice, HPA axis hyper-reactivity was reduced after introducing B. infantis clearly demonstrated that gut microbiota plays a role on modulating HPA axis (Sudo et al., 2004) . Our results demonstrated that chronic corticosterone administration, in addition to having detrimental effects on behaviors, neurochemistry, and corticosterone receptors, also affected gut microbiota composition. Whereas chronic treatment with L-PS23 or H-PS23 had beneficial influences on the enteric microbiota, improved behaviors, and reversed detrimental changes in neurochemistry, corticosterone receptors, and BDNF protein expression in chronic corticosterone-administered mice (Figs. 2, 3, 5 and 6; Table 1 ). Other studies also showed beneficial effects of some bacterial species on stress-induced behavioral changes. For example, chronic treatment of live L. rhamnosus JB-1 in naïve mice (Bravo et al., 2011) , L. plantarum PS128 in ELS mice (Liu et al., 2016b) , and B.
pseudocatenulatum CECT 7765 in obese mice (Agusti et al., 2018) all reduced acute stress-induced corticosterone responses and anxiety-and depression-like behaviors.
Furthermore, administration of a probiotic formulation of L. helveticus R0052 and B. longum R0175 reversed the effect on plasma corticosterone in chronic stressed mice (Ait-Belgnaoui et al., 2014) . Taken together, our results and previous studies demonstrated that gut microbiota is able to modify HPA axis reactivity and associated behaviors.
Bacteria have the capacity to generate many neurotransmitters. For instance, Lactobacillus and Bifidobacterium produce gamma-aminobutyric acid; Lactobacillus produces acetylcholine; Candida, Streptococcus, Escherichia, and Enterococcus produce 5-HT; and Bacillus produces dopamine (Galland, 2014) . Chronic treatment with the same probiotics in different animal models could exhibit different changes in the monoamine levels, indicating it is unlikely that these changes are attributed to a direct production of these monoamines by the probiotics. For example, live PS23 increased dopamine and 5-HT levels in the hippocampus, prefrontal cortex and striatum in SAMP8 mice (Huang et al., 2018) ; whereas in the current study, using chronic corticosterone-treated mice, live PS23 only increased 5-HT levels but not the dopamine level (Table 1) . Live L. plantarum PS128 increased dopamine and 5-HT levels in the prefrontal cortex of naïve mice whereas in the ELS mice it only increased dopamine level in the prefrontal cortex (Liu et al., 2016b ). This view is further supported by a report showing after bifidobacteria-treatment there is a marked increase in serum tryptophan, the 5-HT precursor, but no significant change of 5-HT levels in brain tissues of rats (Desbonnet et al., 2009) . It is also conceivable that the secreted neurotransmitters of bacteria in the intestinal lumen might induce epithelial cells to release molecules to modulate neural signaling within the enteric nervous system or act directly on primary afferent axons (Dinan et al., 2015) .
The local effects of gut microbiota and how these effects influence the central nervous system is currently unclear (Dinan et al., 2015) . Evidences indicate activation of the HPA axis by the gut microbiota can occur as a result of increased permeability of the intestinal barrier and a microbiota-driven proinflammatory state (Farzi et al., 2018) . The administrations of ). In addition, the administrations of L. plantarum PS128 reversed ELS-induced elevation of inflammatory cytokine IL-6 in mice (Liu et al., 2016b) . Previous studies had shown that live PS23 could increase anti-inflammatory cytokine IL-10 and reduce pro-inflammatory cytokines of TNF-α and monocyte chemotactic protein-1 (MCP-1) in the SAMP8 mice (Huang et al., 2018) .
In addition to live preparation, dead probiotics could also exhibit various biological effects, including attenuation of colitis, stimulation of gut immune system, and anti-inflammatory (Adams, 2010; Deshpande et al., 2018) . In addition, repeated subcutaneous immunization with a heat-killed preparation of M. vaccae have been reported to have anxiolytic effects shown by elevated plus-maze test and prevents stressed-induced decreases in brain serotonergic gene expression in a murine model of chronic psychosocial stress (Reber et al., 2016) . Moreover, using a maternal separation stress, we have recently demonstrated that both L-PS23 and H-PS23 modulated stress responses via immunomodulatory effects (Liao et al., In Press) . Therefore, the immunomodulatory effects of live of dead probiotics might play a role in the communication between gut microbiota, neuroendocrine system, and the brain. It has been suggested that live probiotics could influence the gastrointestinal microbiota and have immunomodulatory effects; whereas the components of dead probiotics may exert an anti-inflammatory response (Adams, 2010) .
Although the relative importance of these two effects is difficult to assess, improved safety, longer shelf life, and relatively easy standardization are advantages of dead probiotic preparations over live ones. Our results showed that both L-PS23 and H-PS23 can modulate the HPA axis system and affective behaviors. It should be noted that not all heat-killed lactobacilli show biological effects; for example, only live L. plantarum PS128 but not heat-killed L. plantarum PS128 could increase dopamine and 5-HT levels in prefrontal cortex (Liu et al., 2016a) .
Conclusions
The present study assessed antidepressant-and anxiolytic-like effects of live and heat-killed PS23 on chronic corticosterone-administrated male mice and examined the possible underlying mechanisms. Our findings suggest that the antidepressant-and anxiolytic-like effects of chronic PS23 treatment are due to (1) increases in the hippocampal GR, MR, and BDNF proteins; (2) increases in serotonergic and dopaminergic activities in the hippocampus, prefrontal cortex, and striatum; and (3) improvement of the gut microbiota. By comparing PS23 treatment to chronic administration of fluoxetine, we demonstrated that the effects of probiotics are equivalent or even better than those of this SSRI; with outstanding benefits of improving gut microbiota composition. These findings suggest that probiotics have great potential as alternative therapeutics for alleviating MDD symptoms without the side effects commonly seen in SSRI treatment.
Materials and methods
Animals and ethics
Male C57BL/6J mice (6-8 weeks old) were purchased from the National Laboratory Animal Center (Taipei, Taiwan). Mice were housed under a 12-h light-dark cycle (07:00-19:00 light on) at 21-23 °C and 50-60% humidity. Standard mouse chow (LabDiet Autoclavable Rodent Diet 5010, PMI Nutrition International, Brentwood, MO, USA) and tap water were available ad libitum. Mice were acclimatized for at least 1 week prior to experimentation. All animal behavioral experiments were performed during the light cycle, and the experimental procedures were approved by the Institutional Animal Care and Use Committee of National Yang-Ming University.
Preparation of L. paracasei PS23
PS23 was preserved in our LAB bank and also deposited at the Leibniz Institute DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH with the accession number DSM 32322. PS23 was grown in de Man, Rogosa, and Sharpe broth (Difco Laboratories, Sparks, MD, USA) at 37 °C for 18 h. The bacterium was then harvested and washed twice with saline. PS23 was re-suspended in 15% (w/v) glycerol in de Man, Rogosa, and Sharpe broth, subjected to cell counts, and then stored at -20 °C (used within 10 days).
For daily preparation, the bacterial stock was incubated at 37 °C for 1 h or at 100 °C for 30 min to obtain L-PS23 or H-PS23, respectively. The two stocks were centrifuged at 6000 rpm for 5 min. The pellets were re-suspended in saline and adjusted to 5 × 10 8 cells/ml in saline.
The numbers of live bacteria were also counted 3 days after freezing. daily oral gavage of L-PS23 (10 8 cells/0.2 ml/day) from days 1 to 41, and the H-PS23 group received a daily gavage of H-PS23 at the same dose and duration. All groups except the vehicle group were also subcutaneously injected with 40 mg/kg/day of corticosterone (600 mg/ml in DMSO and diluted to 12 mg/ml with sesame oil; Sigma-Aldrich) from days 17 to 37. The dose and duration of corticosterone treatment were selected based on previous studies to induce anxiety-and depression-like effects in mice (Johnson et al., 2006; Zhao et al., 2008) .
Experimental design
In all experiments, the oral gavage was performed between 14:00 and 15:00 and subcutaneous injection were done 30 min after oral gavage. All the behavioral tests were conducted between days 38 and 42.
Behavioral testing
Open field test
The OFT procedure was based on previous reports (Crupi et al., 2010) . 
Forced swim test
The FST procedure was based on a previous report (Porsolt et al., 1977) . Two forced swimming sessions were conducted. The first session started at 10:00 on day 40 and the second was conducted on day 42. Each mouse was placed in an acrylic cylinder (9 cm diameter × 25 cm height) containing 15 cm of water at 24-25 °C. We videotaped the behaviors of mice in the first test for 6.5 min. To provide a more suitable baseline for detecting antidepressant-like activity, immobility time during the last 6 min was analyzed by Ethovision tracking system software (Version 7.0; Noldus Information Technology, Wageningen, the Netherlands) using a <5% immobility threshold. The cylinder was emptied and cleaned between mice to minimize the odor interference. We also collected a blood sample 30 min before the 6-min test of the second session and another 24 min after the session to evaluate the serum corticosterone change after acute stress (forced swim). The mice were sacrificed after the second session and the brains were collected for regional specific protein and monoamine analysis experiments
Sucrose preference test
The SPT procedure was based on previous reports (Dang et al., 2009; Yi et al., 2012) . Before the test, mice were trained to adapt to sucrose solution by placing two bottles of sucrose solution (1%, w/w) in each cage for 24 h. Then the two bottles were replaced by a bottle of fresh sucrose solution (right placement) and a bottle of water (left placement) for 24 h. Mice were then deprived of sucrose solution, water, and food for 18 h, followed by the sucrose intake test at 10:00 (on day 41). During the test mice were given one bottle of 100 ml sucrose solution (left placement) and one bottle of water (right placement) for 5 h. The weight of both bottles was recorded before and after the test. The sucrose preference was calculated as percentage of sucrose consumed to total sucrose and water consumption: sucrose preference (%) = sucrose consumption (g)/[sucrose consumption (g) + water consumption (g)] × 100. All tests were performed in the home cage to minimize environmental variables.
Body weight, fecal pellets, blood, and brain tissue sample collections
The body weight of mice was measured once a week before oral gavage. We calculated the relative body weight by comparing the weekly body weight with the first week weight. On day 38 of the experiment after the mice completed the OFT, we collected three or four fecal pellets from the test chamber and placed them in a tube containing 0.3 ml of RNAlater RNA stabilization reagent (Qiagen, Hilden, Germany). The tube was then weighed (wet weight) and stored at -20 °C for later gut microbiome analysis. On day 42, we collected the blood samples 30 min before the FST by orbital sinus sampling (0.1-0.2 ml) between 10:00 and 11:00 to minimize the effect of circadian rhythm (Leitch et al., 2003) and blood sampling stress (Teilmann et al., 2014) on corticosterone release. Twenty-four min after the FST, we collected the second blood samples and sacrificed the animals. We then quickly removed the brain, and the hippocampus, prefrontal cortex, and striatum were dissected out immediately.
Two hippocampi were collected for the analyses of the proteins and monoamine in the same mouse. The brain tissues were weighted and stored at -80 °C. The blood samples were allowed to clot at room temperature and then centrifuged at 3000 ×g for 10 min at 4 °C. We then collected the supernatant (serum) and stored it at -80 °C.
Serum corticosterone measurement
The serum corticosterone concentration was determined in duplicates by a commercial corticosterone enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, USA)
following the manufacturer's instructions.
Brain protein analysis
Brain tissues were homogenized in a cold RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150
mM NaCl, 1% NP-40 [Nacalai Tesque, Kyoto, Japan], 0.5% sodium deoxycholate, 0.1% SDS, and 1% protease inhibitor [Sigma-Aldrich]), kept on ice for 1 h, and then centrifuged at 12,000 ×g for 10 min at 4 °C. The resulting supernatant was stored at -80 °C until use. 
Brain monoamine analysis
The brain monoamine analysis was conducted as previously described (Hao et al., 2013) , with some modifications. The brain tissues were homogenized in a cold solution of 1% perchloric acid containing 0.1 mM EDTA and 0.1 mM Na2S2O5, kept on ice for 1 h, and then centrifuged at 12,000 ×g for 10 min at 4 °C. The resulting supernatant was filtered (0.22 μm) and stored at -80 °C until use. Monoamine in the supernatant (20 μl) was measured by HPLC with a C18 column (100 × 2.1 mm, 2.6 μm; Phenomenex, Torrance, CA, USA) coupled with an electrochemical detector (ECD; LC-4C; BAS, West Lafayette, PA, USA). The mobile phase was 100 mM NaH2PO4 (pH 3.74) containing 0.027 mM EDTA, 0.74 mM octane-1-sulfonic acid sodium salt, 2 mM KCl, and 8% methanol, and the flow rate was 0.7 ml/min. The concentrations of monoamines including dopamine, dihydroxyphenylacetic acid (DOPAC), homovanillic acid, 5-HT, and 5-hydroxyindoleacetic acid (5-HIAA) were quantified by comparing the retention time and peak area to the standard solutions of each compound (Sigma-Aldrich) and expressed as nanograms per gram of fresh brain weight.
Statistical analysis
Distribution of data related to normality was assessed by goodness-of-fit test. Normally distributed data were tested using one-way ANOVA followed by heat-killed PS23. quantitative PCR analysis using group-specific primers ( .06 (0.05, 0.07) 0.14 (0.12, 0.14) 128.4 (125.0, 152.9) 181.6 (165.7, 192.5) 1.33 (1.20, 1.44) Tissues from mice treated with Lactobacillus paracasei PS23 (PS23) and corticosterone as the schematic representation shown in Fig. 1 were collected, homogenized, and subjected to an HPLC-ECD analysis. Data with normal or non-normal distribution of 8 mice are expressed as mean ± SEM or median (25th, 75th percentile), respectively. One-way ANOVA followed by Newman-Keuls multiple comparison test: different letters indicate significant differences. Nonparametric comparisons for each pair by Wilcoxon test: # P < 0.05, ## P < 0.01 and ### P < 0.001 vs. vehicle (VEH) group; * P < 0.05 and ** P< 0.01 vs. corticosterone control (CORT) group. L-PS23: live PS23 group; H-PS23: heat-killed PS23; DA: dopamine; DOPAC: dihydroxyphenylacetic acid; HVA: homovanillic acid; 5-HT: 5-hydroxytryptamine; 5-HIAA: 5-hydroxyindoleacetic acid.
